Trials / Unknown
UnknownNCT05976308
Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome
Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome : a Double-blind, Randomized and Placebo-controlled Study
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Jiangxi University of Traditional Chinese Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Polycystic ovary syndrome (PCOS) is a common reproductive disease associated with endocrine and metabolic disorders. Some studies have shown that Chinese herbal medicine is beneficial for PCOS, but the efficacy of Chinese herbal medicine in the treatment of PCOS is not clear, because the quantity of pre-clinical data was limited and the quality of clinical evidence was variable. Therefore, this randomized double-blind placebo-controlled trial aim to evaluate the efficacy of Chinese herbal medicine (Bushen Huatan Decoction) in women with PCOS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bushen Huatan Decoction | The treatment group used Bushen Huatan Decoction, including Tusizi (the seed of Chinese dodder), Fupenzi (Raspberry), Bajitian (Morinda officinalis), Duzhong (Eucommia ulmoides), Shudi (prepared Rehmanniaroot), Fuling (Tuckahoe), Zelan (Aconitum gymnandrum), Zexie (Rhizoma alismatis), Guizhi (Cassia twig), Zhebeimu (Thunberg Fritillary Bulb), Taoren (Peach kernel) and Chuanxiong (Ligusticum wallichii). Subjects take the drug from the first day of inclusion. Take 1 pack each time, bid, for 3 months. |
| DRUG | Placebo | The treatment group used Caramel pigment, Ku Ding Cha Extracts, Maltodextrin, Starch and 5% Bushen Huatan Decoction. |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2025-09-01
- Completion
- 2025-12-01
- First posted
- 2023-08-04
- Last updated
- 2023-09-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05976308. Inclusion in this directory is not an endorsement.